| Mar 11, 2013 |
Synthetic biology project takes flight
|
|
(Nanowerk News) The Technology Strategy Board, the UK’s innovation agency, has awarded over £240,000 to a consortium including two Edinburgh-based companies - Synpromics Ltd and Genabler Ltd - and the University of edinburgh.
|
|
The grant will fund a collaborative project that will seek to use synthetic biology - the design and construction of biological devices and systems - to more effectively create proteins, such as those used in drug manufacture.
|
|
The project, which will begin in May 2013, could help increase production yields in fields such as the manufacturing of biopharmaceuticals.
|
|
Drug advances
|
|
The University has a long history of developing groundbreaking new treatments.
|
|
In the early 1980s, Professor Ken Murray developed the first genetically engineered vaccine against Hepatitis B, saving countless lives across the world.
|
|
Joseph Lister, the father of antisepsis, was Professor of Clinical Surgery at the University. While at Edinburgh, he developed methods to reduce infection in patients.
|
